Evidence map›Paper›PMID 42266166›Full record

ArticlePharmacotherapy2026

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Naheel Said, Giovani Angelotti, Wedad Awad, Asma'a Al-Kharabsheh, An-Kwok Ian Wong, Lama Nazer

Abstract readMulticenter Study
In one paragraph

Article in Pharmacotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naheel SaidDepartment of Pharmacy, King Hussein Cancer Center, Amman, Jordan.ORCID 0009-0000-6055-1371
Giovani AngelottiDalle Molle Institute for Artificial Intelligence, University of Applied Sciences and Arts of Southern Switzerland, Lugano, Switzerland.
Wedad AwadDepartment of Pharmacy, King Hussein Cancer Center, Amman, Jordan.ORCID 0000-0001-7854-4970
Asma'a Al-KharabshehDepartment of Pharmacy, King Hussein Cancer Center, Amman, Jordan.ORCID 0000-0002-9377-6822
An-Kwok Ian WongDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, North Carolina, USA.ORCID 0000-0001-5668-4251
Lama NazerDepartment of Pharmacy, King Hussein Cancer Center, Amman, Jordan.ORCID 0000-0002-7550-4751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveIntravenous magnesium is commonly used in critically ill patients; however, data on the serum level response following its administration are limited. This study aimed to evaluate serum magnesium changes after administration of intravenous magnesium sulfate (IV-MgSO METHODOLOGY: This retrospective multicenter study included adult critically ill patients from the Medical Information Mart for Intensive Care IV and eICU databases. Patients were included if they received IV-MgSO

resultsThe study included 25,637 patients who received 54,556 doses of IV-MgSO

conclusionAmong a large cohort of critically ill patients, 1 g of IV-MgSO

Indexed as

Critical IllnessMagnesiumMagnesium SulfateAdministration, IntravenousAgedFemaleHumansIntensive Care UnitsMaleMiddle AgedRetrospective StudiesMagnesiumMagnesium Sulfatecritical illnesselectrolytesmagnesium sulfatetreatment outcome

Identifiers

PMID42266166
PMCPMC13250669

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.